Dimensional Fund Advisors
ESPR

Dimensional Fund Advisors’s Esperion Therapeutics ESPR Stock Holding History

Dimensional Fund Advisors’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-12,819
Closed -$569K – 3454
2018
Q3 		$569K Sell
12,819
-3,100
-19% -$142K ﹤0.01% 3157
2018
Q2 		$624K Sell
15,919
-70,487
-82% -$3.56M ﹤0.01% 3091
2018
Q1 		$6.25M Sell
86,406
-270
-0.3% -$19.8K ﹤0.01% 2549
2017
Q4 		$5.71M Sell
86,676
-4,074
-4% -$219K ﹤0.01% 2572
2017
Q3 		$4.55M Sell
90,750
-17,923
-16% -$864K ﹤0.01% 2629
2017
Q2 		$5.03M Sell
108,673
-1,802
-2% -$66.3K ﹤0.01% 2580
2017
Q1 		$3.9M Buy
110,475
+70,255
+175% +$1.61M ﹤0.01% 2647
2016
Q4 		$504K Buy
40,220
+14,257
+55% +$170K ﹤0.01% 3088
2016
Q3 		$360K Hold
25,963
– – ﹤0.01% 3110
2016
Q2 		$257K Hold
25,963
– – ﹤0.01% 3144
2016
Q1 		$439K Buy
+25,963
New +$418K ﹤0.01% 3067

Other funds holding ESPR

BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dimensional Fund Advisors's ESPR Position: Q4 2018 in Review

Dimensional Fund Advisors sold out of Esperion Therapeutics (ESPR) in Q4 2018, closing a stake of 12,819 shares — an estimated $569K sold.

Dimensional Fund Advisors first reported a position in ESPR in Q1 2016 and held it in 11 quarters. The position peaked at $6.25M in Q1 2018. 156 funds tracked by Wall St. Rank hold ESPR as of Q4 2018.

  • Dimensional Fund Advisors reported no remaining Esperion Therapeutics position as of Q4 2018 after selling out during the quarter.
  • Dimensional Fund Advisors sold 12,819 Esperion Therapeutics shares in Q4 2018, an estimated $569K.
  • Dimensional Fund Advisors first reported a position in Esperion Therapeutics in Q1 2016 and held it in 11 quarters.
  • Dimensional Fund Advisors's Esperion Therapeutics position peaked at $6.25M in Q1 2018.
  • 156 funds tracked by Wall St. Rank held Esperion Therapeutics as of Q4 2018.

Based on Dimensional Fund Advisors's 13F filing for Q4 2018, filed 13 Feb 2019.